Monoclonal antibodies of hybridomas

Abstract

Among the most prominent biological advances of this century, the hybridoma technology stands out as providing the best tool for the analysis of complex antigens of pathogens and tumor cells. This technology will play a major role in the immunodiagnosis and treatment of infectious and malignant diseases. This review focuses on the most recent developments (1980-1981), with emphasis on human immunology.